Clinical trials
Completed trials in Croatia with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
146 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 7 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 10 |
| 2016 | 7 |
| 2017 | 7 |
| 2018 | 21 |
| 2019 | 18 |
| 2020 | 9 |
| 2021 | 8 |
| 2022 | 8 |
| 2023 | 18 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 146 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Split, School of Medicine | 15 |
| University of Zagreb | 14 |
| University Hospital Dubrava | 8 |
| Clinical Hospital Centre Zagreb | 6 |
| Josip Juraj Strossmayer University of Osijek | 5 |
| Biosense Webster, Inc. | 4 |
| Boston Scientific Corporation | 4 |
| University Hospital of Split | 4 |
| University of Rijeka | 4 |
| Bolt Medical | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 11 |
| Obesity | 6 |
| Pain | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Hemorrhage | 4 |
| Postoperative Pain | 4 |
| Appendicitis | 3 |
| Hemoptysis | 3 |
| Postoperative Cognitive Complications | 3 |
| Respiratory Tract Infections | 3 |
Trials
Showing 1 to 25 of 146. Each trial links to its page on Pharma Observatory.
46 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.